{
  "ptid_time": "127_S_0925_2008-11-21",
  "img_path": "/data/qiuhui/data/adni/images/127_S_0925/2008-11-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 75,689 mm³, 96.5% above the reference mean. With a Z-score of 2.31 (99.0th percentile), this represents significant enlargement; whole brain volume measures 988,414 mm³, 8.4% below the reference mean. With a Z-score of -1.09 (13.7th percentile), this represents mild atrophy. ",
  "text_data": "Age is 76.4 years. Gender is Male. Education: 12 years. MMSE: 24.0. Logical Memory: 6.0. APOEε4 alleles: 0.0. Biomarker levels: Pittsburgh compound B: 1.56 SUVR (normal ); Amyloid beta: 509.90 pg/mL (mild reduced); Total tau: 142.90 pg/mL (mild reduced); Phosphorylated tau: 12.90 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (96.5% above mean, Z-score 2.31) and mild whole-brain atrophy (8.4% below mean, Z-score -1.09), suggesting structural brain changes. The MMSE score of 24 is borderline for cognitive impairment, while CSF biomarkers (Aβ, T-tau, P-tau) are only mildly reduced, not strongly indicative of Alzheimer’s pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Structural changes support impairment, but biomarker profile is not strongly Alzheimer’s-like, and MMSE is borderline.)",
  "timestamp": "2025-07-26T13:04:20.216563"
}